China trial shows Gilead's drug does not show benefits in COVID-19 patients: Lancet

Canada News News

China trial shows Gilead's drug does not show benefits in COVID-19 patients: Lancet
Canada Latest News,Canada Headlines
  • 📰 Reuters
  • ⏱ Reading Time:
  • 30 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 15%
  • Publisher: 97%

Gilead Sciences Inc's experimental drug remdesivir does not speed up recovery from COVID-19 compared with placebo in critically-ill, hospitalised patients, according to data from a trial in China published in the Lancet.

FILE PHOTO: A Gilead Sciences, Inc. office is shown in Foster City, California, U.S. May 1, 2018. REUTERS/Stephen Lam

- Gilead Sciences Inc’s experimental drug remdesivir does not speed up recovery from COVID-19 compared with placebo in critically-ill, hospitalised patients, according to data from a trial in China published in the Lancet. The authors of the study warned that interpreting the trial finding is limited as it was stopped early after they were unable to recruit enough patients due to the steep decline in cases in China.

The authors conclude that more evidence from ongoing clinical trials is needed to better understand if remdesivir can provide meaningful clinical benefit.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Reuters /  🏆 2. in US

Canada Latest News, Canada Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Study Shows Shorter Course of Gilead Drug as Effective Against Covid-19Study Shows Shorter Course of Gilead Drug as Effective Against Covid-19Gilead Sciences said its phase 3 study for the antiviral remdesivir demonstrated that patients with severe Covid-19 taking the drug over a five-day treatment had similar improvement compared with those taking the 10-day course.
Read more »

Gilead Sciences says there are 'positive data' from a study on possible Covid-19 treatment remdesivirGilead Sciences says there are 'positive data' from a study on possible Covid-19 treatment remdesivirThere's 'positive data' emerging from a study on possible Covid-19 treatment remdesivir, the maker of the investigational drug says
Read more »

Gilead says remdesivir shows improvement in COVID-19 patients when used earlyGilead says remdesivir shows improvement in COVID-19 patients when used earlyGilead Sciences Inc on Wednesday said its experimental antiviral drug remdesivir helped improve outcomes for patients with COVID-19, and provided data suggesting it worked better when given earlier in the course of infection.
Read more »

Fu Ying on why China and America must co-operate to defeat covid-19Fu Ying on why China and America must co-operate to defeat covid-19Writing in The Economist, Fu Ying, China's former vice-minister of foreign affairs, argues that to beat the pandemic, the international community needs China and America to co-ordinate
Read more »

China to hold annual parliament meeting after two-month delay as Covid-19 easesChina to hold annual parliament meeting after two-month delay as Covid-19 easesChina announced Wednesday it will hold the country's biggest annual political meeting in May following a two-month delay, the strongest signal yet from the Chinese government that it considers the novel coronavirus outbreak to be under control.
Read more »

Trump administration asks intelligence agencies to find out whether China, WHO hid COVID-19 informationTrump administration asks intelligence agencies to find out whether China, WHO hid COVID-19 informationThe White House has ordered intelligence agencies to establish whether China and the WHO initially hid what they knew about the emerging coronavirus pandemic, current and former U.S. officials familiar with the matter tell NBCNews
Read more »



Render Time: 2025-03-29 22:37:56